A Study of TLC590 for Postsurgical Pain Following Bunionectomy

NCT07222748 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Pain

Interventions

DRUG: TLC590
DRUG: Liposomal Bupivacaine
DRUG: Saline Placebo

Sponsor

TLC Biopharmaceuticals, Inc.